Total pancreatectomy for pancreatic malignancy - from history to the present day
Authors:
M. Ryska; J. Rudiš
Authors‘ workplace:
Chirurgická klinika 2. LF Univerzity Karlovy a ÚVN, Praha, přednosta: prof. MUDr. M. Ryska, CSc.
Published in:
Rozhl. Chir., 2016, roč. 95, č. 10, s. 345-349.
Category:
Review
Overview
Currently, total pancreatectomy (TP) is indicated in approximately one in ten surgical patients with pancreatic cancer. Key role in the decision falls in the competence of the multidisciplinary team, alternatively of the surgeon in the intraoperative period in some cases. Exceptionally, TP is approached in the so-called salvage surgery. Perioperative mortality of TP as an elective procedure does not exceed that of partial resections; however, mortality of up to 50% is associated with salvage surgery in acute postoperative pancreatitis. Postoperatively, patients are afflicted with the so-called brittle diabetes comparable with type 1 diabetes. The aim of our overview is to inform about the current position of TP in the treatment of malignant pancreatic diseases.
Key words:
pancreatic cancer – total pancreatectomy – multidisciplinary team
Sources
1. Almond M, Roberts KJ, Hodson J, et al. Changing indications for a total pancreatectomy: perspectives over a quarter of a century. HPB 2015;17:416−21.
2. Ryska M. Totální pankreatektomie a její současné místo v léčbě onemocnění pankreatu. Gastroent Hepatol 2016;70:1−5.
3. Kausch W. Das Carcinom der Papilla duodeni und seine radikale Entfernung. Beiträge zur klinischen Chirurgie, Tübingen 191278:439−86.
4. Whipple AO, Parsons WB, Mullins CR. Treatment of carcinoma of ampulla of Vater. Ann Surg 1935;102:763−79.
5. Trimble IR, Parsons JW, Sherman CP. A one-stage operation for the cure of carcinoma of the ampulla of Vater and of the head of the pancreas. Surg Gynecol Obstet 1941;73:711–22.
6. Rockey EW. Total pancreatectomy for carcinoma. Case report. Ann Surg 1943;118:603−11.
7. Ihse I, Lilja P, Arnesjö B, et al. Total pancreatectomy for cancer. A appraisal of 65 patients. Ann Surg 1977;186:675−80.
8. Trede M, Schwall G. The complications of pancreatectomy. Ann Surg 1988;207:39−47.
9. Andrén-Sanberg A, Ihse I. Factors influencing survival after total pancreatectomy in patients with pancreatic cancer. Ann Surg 1983;198:605−10.
10. Willet CG, Lewandrowski K, Warshaw AL, et al. Resection margins in carcinoma of the head of the pancreas. Implications for radiation therapy. Ann Surg 1993;217:144−8.
11. Neoptolemos JP, Stocken DD, Dunn JA, et al. Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann Surg 2001;234:758–68.
12. Verbeke CS, Leitch D, Menon KV, et al. Redefining the R1 resection in pancreatic cancer. Br J Surg 2006;93:1232−7.
13. Verbeke CS, Menon KV. Redefining resection margin status in pancreatic cancer. HPB 2009;11:282−9.
14. Yachida S, Jones S, Bozic, I, et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 2010;467:114−7.
15. Yeo TP. Demographics, epidemiology, and inheritance of pancreatic ductal adenocarcinoma. Semin Oncol 2015;42:8−18.
16. Ducreux M, Cuhna AS, Caramella C, et al. Cancer of the pancreas: ESMO clinical practice guidelines for diagnosis, treatment and follow - up. Ann Oncol 2015; 26: suppl. 5: v56−v68.
17. Ryska M, Dušek L, Pohnán R, et al. Kvalita života je důležitým faktorem indikační rozvahy u nemocných s karcinomem pankreatu. Multicentrická prospektivní studie. Rozhl Chir 2012;91:199−208.
18. Coveler AL, Herman JM, Simeone DM, et al. Localized pancreatic cancer: Multidisciplinary management. Am Soc Clin Oncol Educ Book 2016;35:e217−26.
19. Ryska M. Předoperační staging u nemocného s karcinomem pankreatu. Gastroent Hepatol 2015;69:525−9.
20. Rudis J, Ryska M. Pancreatic leakage and acute postoperative pancreatitis after proximal pancreatoduodenectomy. Rozhl Chir 2014;93:380−5.
21. Kulu Y, Schmied BM, Werner J, et al. Total pancreatectomy for pancreatic cancer: indications and operative technique. HPB 2009;11:469−75.
22. Tol JAMG, Gouma DJ, Bassi C, et al. Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma: A consensus statement by the International Study Group on Pancreatic Surgery (ISGPS). Surgery 2014;156:591−600.
23. Hartwig W, Gluth A, Hinz U, et al. Total pancreatectomy for primary pancreatic neoplasms. Ann Surg, 2015;261:537−46.
24. Johnston WC, Hoen HM, Cassera MA, et al. Total pancreatectomy for pancreatic ductal adenocarcinoma: review of the National Cancer Data Base. HPB 2016;18:21−8.
25. Müller MW, Friess H, Kleeff J, et al. Is there still a role for total pancreatectomy? Ann Surg 2007;246: 966−74.
26. Nentwich MF, El Gammal AT, Lemcke T, et al. Salvage completion pancreatectomies as damage control for post-pancreatic surgery complications: a single – center retrospective analysis. World J Surg 2015;39:1550−6.
27. Epelboym I, Winner M, DiNorcia J, et al. Quality of life in patiens after total pancreatectomy is comparable with quality of life in patiens who undergo a partial pancreatic resection. JSR 2014;187:189−96.
28. Watanabe Y, Ohtsuka T, Matsunage T, et al. Long-term outcomes after total pancreatectomy: special reference to survivors´ living conditions and quality of life. World J Surg 2015;39:1231−9.
29. Stauffer JA, Nguyen JH, Heckman MG, et al. Patients ourcomes after total pancreatectomy: a single centre contemporary experience. HPB 2009;11:483−92.
30. Sinn M, Bahra M, Denecke T, et al. Perioperative treatment options in resectable pancreatic cancer − how to improve long-term survival. World J Gastrointest Oncol 2016;15:248−57.
Labels
Surgery Orthopaedics Trauma surgeryArticle was published in
Perspectives in Surgery
2016 Issue 10
Most read in this issue
- Myxofibrosarcoma in the abdominal cavity
- Total pancreatectomy for pancreatic malignancy - from history to the present day
- Complete mesocolic excision during right hemicolectomy
- Liver metastases of malignant melanoma – utility of resection or radiofrequency ablation